Background Central nervous system (CNS) germ cell tumors account for 3 % of all pediatric brain tumors in the USA. Presenting symptoms are typically location based with pineal tumors presenting with obstructive hydrocephalus and suprasellar tumors with hypothalamic/pituitary dysfunction and ophthalmologic abnormalities. Psychiatric manifestations such as psychosis and behavioral changes are atypical presentations of CNS germ cell tumors, with only 11 previously reported cases. Methods This is a retrospective case series describing patients with CNS germ cell tumors with an atypical presentation including psychiatric manifestations. Information regarding clinical presentation, treatment course, and outcome were obtained. Results We report seven patients who presented with psychiatric symptoms consisting of psychomotor delay as well as behavioral and mood changes. Six of the seven patients were diagnosed ≥6 months after onset of psychiatric symptoms. All of the seven are alive but five continue to have neurologic and psychiatric issues post treatment. Conclusions Atypical presentations of CNS germ cell tumors can delay diagnosis and treatment and may be secondary to atypical locations as well as endocrine dysfunction manifesting as psychiatric symptoms. Delayed diagnosis did not appear to affect survival but earlier diagnosis may potentially be associated with better neurologic and psychiatric outcome. Patients who present with these symptoms and atypical neuroimaging should have a thorough evaluation for CNS germ cell tumors including serum and CSF markers. Clinicians should be aware of these less common presentations to aid in prompt diagnosis and treatment.
Introduction
Central nervous system (CNS) germ cell tumors represent 3 % of all pediatric brain tumors in the USA [1] . Typical clinical presentation relates primarily to tumor location, which frequently involves the pineal and suprasellar (SS) regions. Pineal tumors usually cause obstructive hydrocephalus presenting with signs of increased intracranial pressure including headaches, vomiting, lethargy, and Parinaud's syndrome. The most common initial symptom of SS tumors, diabetes insipidus (DI), relates to hypothalamic/pituitary dyfunction; delayed or precocious puberty, growth hormone deficiency, hypothyroidism, and adrenal insufficiency are also seen [2, 3] . Atypical locations or endocrinologic dysfunction may cause a variety of protracted behavioral and psychiatric syndromes, often delaying the medical diagnostic team from suspecting the presence of a primary intracranial tumor such as a germ cell tumor.
We report seven patients with atypical symptoms such as psychomotor delay, behavioral changes, and psychosis. All of these patients had either endocrinologic disturbances or atypical imaging features. To the best of our knowledge, there have only been 11 previously reported atypical psychiatric presentations in seven case reports and one retrospective review article [1, [4] [5] [6] [7] [8] [9] [10] . It is important to recognize that patients with CNS germ cell tumors may present with psychiatric symptoms, which may be secondary to atypical imaging characteristics, metabolic disturbances, or a combination of both. Identification of the uncommon presentation is warranted to reduce the risk of delayed diagnosis.
Methods
We performed a retrospective chart review evaluating patients that presented from 2004 to 2014 with atypical presentations including psychiatric symptoms and were found to have CNS germ cell tumors. Data collected consisted of clinical presentation, treatment, and outcome. The results are descriptive. This retrospective study was approved by Memorial Sloan Kettering Cancer Center and Montefiore Medical Center/ Albert Einstein's Institutional Review Boards and Privacy Boards.
Results
Refer to Table 1 for details of case series.
Discussion
Our case series describes seven patients who presented with psychomotor delay, behavioral changes, psychosis, and other psychiatric symptoms with or without endocrine abnormalities (Table 1) . To the best of our knowledge, there have only been 11 cases reported describing psychiatric manifestations associated with CNS germ cell tumors. In reviewing our cases and the previous literature, the commonality between the cases is atypical location with infiltrative nature. Along with atypical location, our patients also had endocrinologic disturbances that were protracted. Psychiatric manifestations can be seen with endocrine dysfunction and may explain the atypical presentation. This has not been emphasized previously and is very important to highlight for clinicians who may encounter these patients, to avoid delay in diagnosis. All of our patients in this series are alive, and only two had progression of disease, one at 1.5 years and the other at 4 years post initial diagnosis. Delayed diagnosis did not appear to affect survival but earlier diagnosis may be associated with better neurologic and psychiatric outcome.
Previously reported case reports highlighted patients who presented with psychiatric symptoms and were all found to have atypical imaging characteristics with deep gray matter involvement and infiltrating nature [4] [5] [6] [7] [8] . Crawford et al. published a report on presentation of CNS germ cell tumors with relation to location, as well [1] . In this article, the most common presenting symptom was headache in 70 % of patients with pineal region tumors. Patients with delayed diagnosis, which they defined as greater than 6 months, included four patients with suprasellar lesions, three with basal ganglia lesions, one with suprasellar/pineal lesion, and one with a pineal lesion. Common symptoms that were present in this group included enuresis, psychosis, movement disorders, and anorexia. Of the nine patients with delayed diagnosis, three presented with psychiatric symptoms only. Two patients were diagnosed with anorexia nervosa and were both found to have suprasellar lesions, the third presented with poor school performance, change in behavior, and psychosis. With further review of their patient population, 4 of 30 patients had abrupt change in school performance. One patient had tics, obsessive compulsive disorder (OCD), dyskinesia, and progressive school decline and was found to have a lesion involving the basal ganglia, corpus callosum, cerebellum, periventricular white matter, and mesial temporal lobe. Four patients had psychomotor slowing and were all found to have lesions involving deep gray structures including basal ganglia and thalamus. The delay in diagnosis was attributed to less common symptoms, atypical MRI findings, and subtle endocrinologic dysfunction.
Endocrine deficiencies can manifest as psychiatric symptoms [11] . Examples of this include hypercortisolism presenting with depression, cognitive impairment, delirium, and psychosis. Hypocortisolism can also present with depression, cognitive impairment as well as delirium. Hyperthyroidism is associated with nervousness, emotional lability, and hyperkinesia. Diabetes insipidus and hypernatremia have also presented with psychiatric symptoms such as psychosis. It is plausible that patients with CNS germ cell tumors who have pituitary/hypothalamic dysfunction can present with psychiatric symptoms secondary to endocrine deficiencies. This can also cause a delay in diagnosis. In our case series, patients 5 and 7 had endocrine deficiencies only, without atypical/ infiltrative imaging findings. Patients 1, 2, and 6 had both atypical locations with infiltrative features and prolonged endocrine abnormalities.
CNS germ cell tumors can present with symptoms such as OCD, cognitive decline, psychomotor delay, psychosis, hemiparesis, dyskinesias, tics, enuresis, and anorexia and can have nonspecific MRI findings or endocrine dysfunction. Patients who present with endocrine disturbances, especially prolonged or medically refractory, and atypical neuroimaging should have a thorough evaluation for CNS germ cell tumors including serum and CSF markers. We should be aware of these less common presentations as manifestations of CNS germ cell tumors to aid in prompt diagnosis and treatment to potentially prevent poor neurologic and psychiatric outcomes.
